Browse the evidence

Lifestyle interventions demonstrate favorable effects on lipid metabolism independent of weight loss.

Encourage patients to adopt lifestyle changes for lipid management, even if weight loss is not achieved.

Roux-en-Y gastric bypass was associated with less gastroesophageal reflux disease (GERD)-related symptoms compared to sleeve gastrectomy.

Surgeons may prefer Roux-en-Y gastric bypass for patients concerned about GERD symptoms.

GLP-1 receptor agonists (GLP-1 RAs) have been presumed to positively influence erectile function.

GLP-1 RAs may be considered in the management of erectile function in diabetic patients.

Obesity significantly influences the incidence and progression of various cancers.

Practitioners should consider obesity as a critical factor in cancer risk assessment.

Obesity is linked to increased cancer susceptibility and adverse prognostic outcomes.

Awareness of obesity's impact on cancer outcomes is essential for patient management.

Surgical therapies including laparoscopic bariatric surgery represent an important treatment strategy in obese patients.

Practitioners should consider bariatric surgery for eligible obese patients.

Combining medications with bariatric surgery may improve long-term outcomes for T2DM management.

Clinicians should consider integrating pharmacotherapy with surgical interventions for better management of T2DM.

Expert consensus has defined a state of diabetes remission where treatment can induce sustained normalization of glucose levels.

Understanding this definition can help practitioners set realistic treatment goals.

Tirzepatide was recently approved for the management of obesity.

Tirzepatide can be considered as a treatment option for obesity management.

Tirzepatide manages blood sugar levels and enhances weight loss more than GLP-1 receptor agonists.

Tirzepatide may be more effective than GLP-1 receptor agonists for patients needing blood sugar and weight management.

Continuing GLP-1 or GIP agonists before upper endoscopy increases the risk of clinically significant residual gastric volume (RGV).

Practitioners should consider holding GLP-1 or GIP agonists prior to upper endoscopy to reduce the risk of RGV.

Holding one dose of GLP-1 or GIP agonists significantly reduces the risk of clinically significant RGV.

Holding the medication prior to the procedure is advisable to minimize RGV risk.

Clear liquids the day prior to the procedure may mitigate the risk of clinically significant RGV regardless of GLP-1/GIP use.

Encouraging clear liquids before procedures may help reduce RGV risk.

MNs hold promise in improving the quality of life for individuals struggling with obesity and its associated comorbidities.

MNs may enhance treatment efficacy and patient outcomes in obesity management.

Tirzepatide is available for the treatment of hyperglycemia in patients with type 2 diabetes.

Practitioners can consider tirzepatide as a treatment option for managing hyperglycemia in type 2 diabetes patients.

Powerlifters had significantly greater training duration and absolute squat and bench press 1RM compared to recreationally strength-trained subjects.

Powerlifting training may lead to greater strength gains compared to recreational strength training.

Significant negative relationships were found between 2-lift Wilks score and shoulder extension and horizontal abduction, as well as hip flexion and extension.

Improving shoulder and hip ROM may enhance strength performance in powerlifters.

Sarcopenia is characterized by the progressive and generalized loss of muscle mass and strength, negatively impacting health and quality of life.

Understanding sarcopenia is crucial for developing interventions to improve health in aging populations.

Tirzepatide is a novel treatment option for Type 2 diabetes mellitus (T2DM) that may benefit individuals with cardiovascular disease or heart failure.

Tirzepatide may be considered for T2DM patients with cardiovascular concerns.

Physical activity contributes principally to the maintenance of weight loss rather than the induction of weight loss.

Emphasize physical activity for maintaining weight loss in treatment plans.

The study suggests that patient-delivered interventions may be effective in community and clinical settings for weight loss maintenance.

Consider exploring patient-delivered interventions in various settings for effective weight maintenance.

Coconut milk supplementation induced beneficial changes in the lipid profile, decreasing LDL and non-HDL levels while increasing HDL levels.

Incorporating coconut milk into the diet may improve lipid profiles, particularly for individuals with elevated LDL levels.

The subgroup with elevated baseline LDL levels benefited most from coconut milk supplementation.

Individuals with high LDL levels may see greater improvements in their lipid profiles by consuming coconut milk.

The MC4R rs17782313 polymorphism has positive effects on dietary glycemic index (GI) and glycemic load (GL) (B = 1.577; P ≤ 0.01 for GI; B = 1.235; P ≤ 0.01 for GL).

Understanding the genetic basis of GI and GL can inform dietary recommendations for obesity management.